Medtronic announced the primary and secondary outcomes of the VenaSeal Spectrum Venous Leg Ulcer study. According to the ...

Cordis announced new data from the SUCCESS PTA and SELUTION SFA Japan peripheral studies evaluating the company’s Selution ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

Penumbra recently announced the introduction of the Red 72 Silver Label large-bore reperfusion catheter with SendIt technology. T ...

CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study demonstrat ...

R3 Vascular Inc. announced that the first patient was enrolled in the company’s ELITE-BTK pivotal trial evaluating its Magn ...

Acute ischemic stroke (AIS) is the leading cause of adult disability in the United States and a major cause of death both ...